In-licensing
Up-to-date access to technology licensing opportunities worldwide.
- In-licensing
- Browse
Licensing opportunities
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 396 pages - $2,265
Aug 2008 - 120 pages - $1,040
Oct 2010 - 46 pages - $895
Oct 2010 - 46 pages - $895
Oct 2010 - 43 pages - $895
Oct 2010 - 43 pages - $895
May 2011 - 47 pages - $895
Oct 2010 - 43 pages - $895
Oct 2010 - 32 pages - $895
May 2011 - 46 pages - $895
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Disseminated intravascular coagulation
- Dyslipidemia
- Hypercholesterolemia
- Hyperlipidemia
- Hypertriglyceridemia
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us